Replies to post #7000 on Arch Therapeutics Inc (ARTH)

[tfris]

Hi Regis
Really, for less than $50 a year the conference calls are worth it alone-did you know of ARTH before stockgumshoe through MIT connections? Just wondering. If you sit in on call with Dr. Norchi, can you ask him what he expects gross yearly sales could be with external use approval? Thanks for all you do.
Tim

[UFO]

Hey Regis999. You missed the point in my posting of the "far behind" 2014/2015 Stock Gumshoe pieces by Dr.KSS. These were the first articles that introduced Arch to the investing world and had information about the firm and the product that was generally not easy to locate elsewhere. I posted subsequently that the articles were dated. Interestingly, I, like a lot of others, didn't hear about $ARTH from Gumshoe initially. I also hang out at Stockscores.com and Arch hit my radar when the stock jumped to a 98/80 (high) rating during an earlier part of the rally. Anyone who uses any type of stock screener would have seen $ARTH's move higher. From there I went to Gumshoe (I'm a pay member also) and looked them up and voila...here we are. So, anyone who feels $ARTH's current price increase should be blamed on two tweets (KSS articles) is patently wrong (are you reading this bryan2464). Stocks end up on peoples' watch lists many different ways.

UFO